| Industry | 科学研究和技术服务业 | ||||||||||||||||||||||||
| Company Introduction | 上海奥浦迈生物科技股份有限公司（股票简称：奥浦迈，股票代码：688293）成立于2013年，是一家专注于提供细胞培养解决方案和端到端CDMO服务的高科技生物技术企业。奥浦迈拥有4个符合GMP标准的生产基地，总面积超18,000平方米。另有总面积约30,000平方米的新总部正处于建设阶段。 2022年，奥浦迈登陆科创板，踏上新的征程。我们将继续依托国际领先的技术研发团队和完整的商业化生产质量管理体系，秉承“至臻工艺、至善品质”的质量方针，持续优化和创新。 奥浦迈以提供多样化、高性能、质量高度稳定的产品为核心准则，以快速响应、精益求精的服务态度，提供卓越、稳定、个性化的“一站式”细胞培养解决方案，成为了全球制药企业的重要战略合作伙伴。 | ||||||||||||||||||||||||
| Main Business | 细胞培养产品与服务 | ||||||||||||||||||||||||
| Legal Representative | 肖志华 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 倪亮萍 | ||||||||||||||||||||||||
| Solicitors | 北京金诚同达律师事务所 | ||||||||||||||||||||||||
| Auditors | 立信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 021-20780178 | ||||||||||||||||||||||||
| Fax No | 021-68101069 | ||||||||||||||||||||||||
| Website | www.opmbiosciences.com | ||||||||||||||||||||||||
| ir@opmbiosciences.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 02/09/2022 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.470 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.440 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 18.808 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.137B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |